183 related articles for article (PubMed ID: 7975832)
21. alpha beta T cell receptor-positive intraepithelial lymphocytes with CD4+, CD8- and CD4+, CD8+ phenotypes from orally immunized mice provide Th2-like function for B cell responses.
Fujihashi K; Yamamoto M; McGhee JR; Kiyono H
J Immunol; 1993 Dec; 151(12):6681-91. PubMed ID: 7903096
[TBL] [Abstract][Full Text] [Related]
22. Lack of antigen-specific immune responses in anti-IL-7 receptor alpha chain antibody-treated Peyer's patch-null mice following intestinal immunization with microencapsulated antigen.
Kunisawa J; Takahashi I; Okudaira A; Hiroi T; Katayama K; Ariyama T; Tsutsumi Y; Nakagawa S; Kiyono H; Mayumi T
Eur J Immunol; 2002 Aug; 32(8):2347-55. PubMed ID: 12209648
[TBL] [Abstract][Full Text] [Related]
23. Mucosal immunity: regulation by helper T cells and a novel method for detection.
Jackson RJ; Marinaro M; VanCott JL; Yamamoto M; Okahashi N; Fujihashi K; Kiyono H; Chatfield SN; McGhee JR
J Biotechnol; 1996 Jan; 44(1-3):209-16. PubMed ID: 8717406
[TBL] [Abstract][Full Text] [Related]
24. Oral tolerance revisited: prior oral tolerization abrogates cholera toxin-induced mucosal IgA responses.
Kato H; Fujihashi K; Kato R; Yuki Y; McGhee JR
J Immunol; 2001 Mar; 166(5):3114-21. PubMed ID: 11207263
[TBL] [Abstract][Full Text] [Related]
25. Humoral and cellular immune responses in the murine respiratory tract following oral immunization with cholera toxin or Escherichia coli heat-labile enterotoxin.
Ruedl C; Rieser C; Kofler N; Wick G; Wolf H
Vaccine; 1996 Jun; 14(8):792-8. PubMed ID: 8817827
[TBL] [Abstract][Full Text] [Related]
26. Interferon-gamma receptor-deficient mice exhibit impaired gut mucosal immune responses but intact oral tolerance.
Kjerrulf M; Grdic D; Ekman L; Schön K; Vajdy M; Lycke NY
Immunology; 1997 Sep; 92(1):60-8. PubMed ID: 9370925
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin.
Takahashi I; Marinaro M; Kiyono H; Jackson RJ; Nakagawa I; Fujihashi K; Hamada S; Clements JD; Bost KL; McGhee JR
J Infect Dis; 1996 Mar; 173(3):627-35. PubMed ID: 8627026
[TBL] [Abstract][Full Text] [Related]
28. Anti-cholera toxin IgA-, IgG- and IgM-secreting cells in various rat lymphoid tissues after repeated intestinal or parenteral immunizations.
Solbreux PM; Dive C; Vaerman JP
Immunol Invest; 1990; 19(5-6):435-51. PubMed ID: 2074113
[TBL] [Abstract][Full Text] [Related]
29. Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen.
Boyaka PN; Tafaro A; Fischer R; Leppla SH; Fujihashi K; McGhee JR
J Immunol; 2003 Jun; 170(11):5636-43. PubMed ID: 12759444
[TBL] [Abstract][Full Text] [Related]
30. Expression of recombinant enterotoxigenic Escherichia coli colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell response.
Pascual DW; Hone DM; Hall S; van Ginkel FW; Yamamoto M; Walters N; Fujihashi K; Powell RJ; Wu S; Vancott JL; Kiyono H; McGhee JR
Infect Immun; 1999 Dec; 67(12):6249-56. PubMed ID: 10569734
[TBL] [Abstract][Full Text] [Related]
31. Cholera holotoxin and its B subunit enhance Peyer's patch B cell responses induced by orally administered influenza virus: disproportionate cholera toxin enhancement of the IgA B cell response.
Chen KS; Strober W
Eur J Immunol; 1990 Feb; 20(2):433-6. PubMed ID: 2311649
[TBL] [Abstract][Full Text] [Related]
32. Mucosal immunization with purified flagellin from Salmonella induces systemic and mucosal immune responses in C3H/HeJ mice.
Strindelius L; Filler M; Sjöholm I
Vaccine; 2004 Sep; 22(27-28):3797-808. PubMed ID: 15315861
[TBL] [Abstract][Full Text] [Related]
33. Orally administered cholera toxin prevents murine intestinal T cells from staphylococcal enterotoxin B-induced anergy.
Iijima H; Takahashi I; Hiroi T; Shimaoka M; Kawano S; Nagano K; Hori M; Kiyono H
Gastroenterology; 1998 Nov; 115(5):1197-204. PubMed ID: 9797375
[TBL] [Abstract][Full Text] [Related]
34. Use of intranasal IL-12 to target predominantly Th1 responses to nasal and Th2 responses to oral vaccines given with cholera toxin.
Marinaro M; Boyaka PN; Jackson RJ; Finkelman FD; Kiyono H; Jirillo E; McGhee JR
J Immunol; 1999 Jan; 162(1):114-21. PubMed ID: 9886376
[TBL] [Abstract][Full Text] [Related]
35. A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity.
Yamamoto S; Kiyono H; Yamamoto M; Imaoka K; Fujihashi K; Van Ginkel FW; Noda M; Takeda Y; McGhee JR
Proc Natl Acad Sci U S A; 1997 May; 94(10):5267-72. PubMed ID: 9144226
[TBL] [Abstract][Full Text] [Related]
36. Characterization of cytokine-producing cells in mucosal effector sites: CD3+ T cells of Th1 and Th2 type in salivary gland-associated tissues.
Hiroi T; Fujihashi K; McGhee JR; Kiyono H
Eur J Immunol; 1994 Nov; 24(11):2653-8. PubMed ID: 7957557
[TBL] [Abstract][Full Text] [Related]
37. Differential effect of aging on B-cell immune responses to cholera toxin in the inductive and effector sites of the mucosal immune system.
Haq JA; Szewczuk MR
Infect Immun; 1991 Sep; 59(9):3094-100. PubMed ID: 1879933
[TBL] [Abstract][Full Text] [Related]
38. Release from Th1-type immune tolerance in spleen and enhanced production of IL-5 in Peyer's patch by cholera toxin B induce the glomerular deposition of IgA.
Yamanaka T; Tamauchi H; Suzuki Y; Suzuki H; Horikoshi S; Terashima M; Iwabuchi K; Habu S; Okumura K; Tomino Y
Immunobiology; 2016 Apr; 221(4):577-85. PubMed ID: 26719095
[TBL] [Abstract][Full Text] [Related]
39. Adoptive transfer of gut mucosal antitoxin memory by isolated B cells 1 year after oral immunization with cholera toxin.
Lycke N; Holmgren J
Infect Immun; 1989 Apr; 57(4):1137-41. PubMed ID: 2784416
[TBL] [Abstract][Full Text] [Related]
40. CD19-deficient mice exhibit poor responsiveness to oral immunization despite evidence of unaltered total IgA levels, germinal centers and IgA-isotype switching in Peyer's patches.
Gärdby E; Lycke NY
Eur J Immunol; 2000 Jul; 30(7):1861-71. PubMed ID: 10940875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]